 |
|
|
| |
Impact of Acid-Reducing Agents on Effectiveness of Elbasvir/Grazoprevir in Treating US Veterans Affairs Population with Hepatitis C Virus
|
| |
| |
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Jennifer R. Kramer1,2; Amy Puenpatom3; Yumei Cao1; Donna Smith1; Hashem El-Serag1,2; Fasiha Kanwal1,2
1IQuESt, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX; 2Department of Medicine, Baylor College of Medicine, Houston, TX; 3Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ, USA
|
| |
|
|
|
|
|
